Kingnew Pharmaceuticals: The Fourth Phase Employee Stock Ownership Plan's first holder meeting passed multiple resolutions.

The announcement of Jin Xin Pharmaceutical Industry stated that on January 21, 2026, the first holder meeting of the fourth phase of the employee stock ownership plan was held, with 215 people in attendance, representing 66.315 million shares, accounting for 74.48% of the total shares. The meeting approved three proposals. First, establish a management committee consisting of three members. Second, elect Chen Bin, Wu Xiuyan, and Zhang Bo as members, with Chen Bin as the director, and their terms of office are consistent with the duration of the employee stock ownership plan. Third, authorize the management committee to handle matters related to this employee stock ownership plan, including convening meetings, deciding on the disposal of shares, and exercising shareholder rights.